Diabetes
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
WEDNESDAY, Oct. 14, 2020 (HealthDay News) — Sitagliptin treatment added to standard care is associated with reduced mortality and improved clinical outcomes for patients with type 2 diabetes hospitalized with COVID-19, according to a study published online Sept. 29 in Diabetes Care. Sebastiano Bruno Solerte, from the University of Pavia in Italy, and colleagues conducted...
Manufacturer Prices for Insulin Substantially Higher in the U.S.
FRIDAY, Oct. 9, 2020 (HealthDay News) — Manufacturer prices of insulin are considerably higher in the United States than in other countries, according to a report published by the RAND Corporation. Andrew W. Mulcahy, Ph.D., from RAND Health Care Communications in Santa Monica, California, and colleagues compared prices of insulins in the United States relative...
T2DM Links to Risk for Dementia Differ by Type, Glycemic Control
FRIDAY, Oct. 9, 2020 (HealthDay News) — Patients with type 2 diabetes (T2D) are more likely to develop vascular dementia and nonvascular dementia compared with controls without diabetes, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held virtually from Sept. 21 to 25. Carlos Celis-Morales,...
DKA Episode May Harm Cognitive Function in Children With T1D
FRIDAY, Oct. 9, 2020 (HealthDay News) — A single diabetic ketoacidosis (DKA) episode is associated with subtle memory declines soon after type 1 diabetes diagnosis in children, according to a study published online Sept. 22 in Diabetes Care. Simona Ghetti, from the University of California, Davis, and colleagues assessed whether a single DKA episode is...
Disparities in Insulin Pump Use Persist, 2005 to 2019
FRIDAY, Oct. 9, 2020 (HealthDay News) — Racial disparities in insulin pump use among children with type 1 diabetes (T1D) have persisted for 15 years, according to a study published in the November issue of the Journal of Pediatric Nursing. Terri H. Lipman, from University of Pennsylvania School of Nursing in Philadelphia, and colleagues retrospectively...
28 Percent With T1DM Received Remote Care in Pandemic
THURSDAY, Oct. 8, 2020 (HealthDay News) — Twenty-eight percent of individuals with type 1 diabetes reported receiving remote care during the pandemic, according to a study recently published in Endocrinology, Diabetes & Metabolism to coincide with the annual meeting of the European Association for the Study of Diabetes, held virtually from Sept. 21 to 25....
Exercise Lowers Mortality for Patients With Type 2 Diabetes
FRIDAY, Oct. 2, 2020 (HealthDay News) — Exercise cuts the risk for death in patients with type 2 diabetes, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held virtually from Sept. 21 to 25. Yun-Ju Lai, M.D., from the Taichung Veterans General Hospital in Taiwan,...
Pancreas Size, Shape Restored With Remission of T2DM
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Pancreas size and shape can be restored with remission of type 2 diabetes, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held virtually from Sept. 21 to 25. Roy Taylor, M.B., Ch.B., M.D., from Newcastle University in the...
Hospital Admissions Not Related to COVID-19 Fell in Early 2020
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in Health Affairs. John D. Birkmeyer, M.D., from Sound Physicians in Tacoma, Washington, and colleagues conducted a...
More Medical News
